Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
American Journal of Physiology. Renal Physiology|October 9, 2015
Developing novel chemical entities for the treatment of lysosomal storage disorders: an academic perspectiveJames A ShaymanExpert Review of Endocrinology & Metabolism|February 10, 2019
Eliglustat tartrate, a prototypic glucosylceramide synthase inhibitorJames A ShaymanSeminars in Nephrology|April 1, 2018
Targeting Glucosylceramide Synthesis in the Treatment of Rare and Common Renal DiseaseJames A ShaymanCell Chemical Biology|October 22, 2016
Adding Lyso-Lipids to Arachidonate Metabolism Sets the Stage for New BiologyJames A ShaymanTransactions of the American Clinical and Climatological Association|July 23, 2013
The design and clinical development of inhibitors of glycosphingolipid synthesis: will invention be the mother of necessity?James A ShaymanBiochimica Et Biophysica Acta|September 11, 2012
Drug induced phospholipidosis: an acquired lysosomal storage disorderJames A Shayman, Akira AbeThe Journal of Biological Chemistry|May 29, 2003
Src kinase mediates the regulation of phospholipase C-gamma activity by glycosphingolipidsLiming Shu, James A ShaymanThe Journal of Biological Chemistry|May 31, 2007
Caveolin-associated accumulation of globotriaosylceramide in the vascular endothelium of alpha-galactosidase A null miceLiming Shu, James A ShaymanPageof 10